Real-life experience of lusutrombopag for cirrhotic patients with low platelet counts being prepared for invasive procedures-Reference-Cited by-同舟云学术

Real-life experience of lusutrombopag for cirrhotic patients with low platelet counts being prepared for invasive procedures

Published:2019-02-15 Issue:2 Volume:14 Page:e0211122
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Takada Hitomi,Kurosaki Masayuki,Nakanishi Hiroyuki,Takahashi Yuka,Itakura Jun,Tsuchiya Kaoru,Yasui Yutaka,Tamaki Nobuharu,Takaura Kenta,Komiyama Yasuyuki,Higuchi Mayu,Kubota Youhei,Wang Wann,Okada Mao,Shimizu Takao,Watakabe Keiya,Enomoto Nobuyuki,Izumi Namiki^ORCID

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference24 articles.

1. Thrombocytopenia associated with chronic liver disease;N Afdhal;J Hepatol,2008

2. Review article: thrombocytopenia in chronic liver disease and pharmacologic treatment options;EG Giannini;Aliment Pharmacol Ther,2006

3. Lusutrombopag: First Global Approval;ES Kim;Drugs,2016

4. Investigation of the freely available easy-to-use software 'EZR' for medical statistics;Y Kanda;Bone Marrow Transplant,2013

5. Lusutrombopag increases hematocytes in a compensated liver cirrhosis patient;A Sakamaki;Clin J Gastroenterol,2017

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Final Results from the First European Real-World Experience on Lusutrombopag Treatment in Cirrhotic Patients with Severe Thrombocytopenia: Insights from the REAl-World Lusutrombopag Treatment in ITalY Study;Journal of Clinical Medicine;2024-07-06

2. Lusutrombopag Reduces the Risk of Hemoperitoneum Caused by Percutaneous Radiofrequency Ablation for Hepatocellular Carcinoma Compared with Platelet Transfusion;Digestive Diseases;2024-04-25

3. A study on prevention of bleeding complications using lusutrombopag for safe RFA in patients with hepatocellular carcinoma with low platelet counts: prospective observational study;BMC Gastroenterology;2023-07-24

4. The evolving knowledge on primary hemostasis in patients with cirrhosis: A comprehensive review;Hepatology;2023-02-27

5. Safe radiofrequency ablation for low platelet count patients with a novel platelet count raising drug (lusutrombopag): Prospective Observational Study;2023-01-18